Angiotensin II AT(1)-receptor induces biglycan in neonatal cardiac fibroblasts via autocrine release of TGFbeta in vitro
After myocardial infarction, angiotensin II (AngII) promotes ventricular remodeling and deposition of extracellular matrix (ECM), e.g., collagen type 1 and 3. Whether AngII regulates the expression of small leucine-rich proteoglycans (SLRP) which are important modulators of collagen fibrillogenesis...
Gespeichert in:
| Veröffentlicht in: | Cardiovascular research 2003-12, Vol.60 (3), p.538-546 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 546 |
|---|---|
| container_issue | 3 |
| container_start_page | 538 |
| container_title | Cardiovascular research |
| container_volume | 60 |
| creator | Tiede, Karen Stöter, Katrin Petrik, Christian Chen, Wen Bin Ungefroren, Hendrik Kruse, Marie Luise Stoll, Monika Unger, Thomas Fischer, Jens W |
| description | After myocardial infarction, angiotensin II (AngII) promotes ventricular remodeling and deposition of extracellular matrix (ECM), e.g., collagen type 1 and 3. Whether AngII regulates the expression of small leucine-rich proteoglycans (SLRP) which are important modulators of collagen fibrillogenesis and are induced after experimental myocardial infarction in rats is not known. The aim of the present study was therefore to analyse in cultured cardiac fibroblasts the expression and secretion of the SLRP biglycan in response to AngII.
Cardiac fibroblasts were isolated from neonatal Wistar Kyoto rats and used in the first passage. Expression of AT(1)- and AT(2)-receptors was verified by RT-PCR. Expression of protoeglycans was analyzed after metabolic labeling with [35S]-sulfate, by SDS-PAGE and Western analysis. In addition, mRNA expression was examined by means of RT-PCR and Northern analysis. The activity of the biglycan promoter was analyzed using three biglycan promoter-luciferase fusion constructs.
Biglycan was found to be the predominant proteoglycan produced by neonatal cardiac fibroblasts in vitro. In response to AngII (10(-7) M), secretion of total [35S]-labeled proteoglycans and mRNA of biglycan were increased to 116+/-1.8% and 121+/-11% (n=5, mean+/-S.E.M.) of unstimulated controls, respectively. Biglycan induction in response to AngII was sensitive to Losartan (10(-5) M) and unaffected by PD123177 (10(-6) M), suggesting that the AT(1)-receptor mediates the induction of biglycan. Direct activation of the biglycan promoter downstream of the AT(1)-receptor was excluded by promoter activity assays. Instead, increased release of transforming growth factor beta 1 (TGFbeta1) was detected by ELISA in response to AT(1)-receptor stimulation. Furthermore, neutralising antibodies to TGFbeta1 inhibited biglycan induction in response to AngII.
The results indicate that in cardiac fibroblasts AngII via the AT(1)-receptor causes autocrine release of TGFbeta1, which in turn induces biglycan expression and secretion. |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_71434981</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71434981</sourcerecordid><originalsourceid>FETCH-LOGICAL-p549-46d71eaddf0851a4aef6246fb898fe609d766c58a0b07f9f8c1c86ab1896aba63</originalsourceid><addsrcrecordid>eNo1UFFLwzAY7IPi5vQvSJ5EHwqJTdPkcQw3BwNf-l6-pF9GpEtqkg73762oL3fccRzcXRVLSqksRSWqRXGb0scs67rhN8WCcVGrRqll8bX2Rxcy-uQ82e_Jun1iz2VEg2MOkTjfTwYT0e44XAz42SAeg4cMAzEQeweGWKdj0AOknMjZAYEpBxOdRxJxQEhIgiXtbqsxw0_B2eUY7oprC0PC-z9eFe32td28lYf33X6zPpRjzVXJRd8whL63VNYMOKAVL1xYLZW0KKjqGyFMLYFq2lhlpWFGCtBMqhlBVKvi8bd2jOFzwpS7k0sGhwHmGVPqGsYrriSbgw9_wUmfsO_G6E4QL93_VdU36ullrg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71434981</pqid></control><display><type>article</type><title>Angiotensin II AT(1)-receptor induces biglycan in neonatal cardiac fibroblasts via autocrine release of TGFbeta in vitro</title><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Tiede, Karen ; Stöter, Katrin ; Petrik, Christian ; Chen, Wen Bin ; Ungefroren, Hendrik ; Kruse, Marie Luise ; Stoll, Monika ; Unger, Thomas ; Fischer, Jens W</creator><creatorcontrib>Tiede, Karen ; Stöter, Katrin ; Petrik, Christian ; Chen, Wen Bin ; Ungefroren, Hendrik ; Kruse, Marie Luise ; Stoll, Monika ; Unger, Thomas ; Fischer, Jens W</creatorcontrib><description>After myocardial infarction, angiotensin II (AngII) promotes ventricular remodeling and deposition of extracellular matrix (ECM), e.g., collagen type 1 and 3. Whether AngII regulates the expression of small leucine-rich proteoglycans (SLRP) which are important modulators of collagen fibrillogenesis and are induced after experimental myocardial infarction in rats is not known. The aim of the present study was therefore to analyse in cultured cardiac fibroblasts the expression and secretion of the SLRP biglycan in response to AngII.
Cardiac fibroblasts were isolated from neonatal Wistar Kyoto rats and used in the first passage. Expression of AT(1)- and AT(2)-receptors was verified by RT-PCR. Expression of protoeglycans was analyzed after metabolic labeling with [35S]-sulfate, by SDS-PAGE and Western analysis. In addition, mRNA expression was examined by means of RT-PCR and Northern analysis. The activity of the biglycan promoter was analyzed using three biglycan promoter-luciferase fusion constructs.
Biglycan was found to be the predominant proteoglycan produced by neonatal cardiac fibroblasts in vitro. In response to AngII (10(-7) M), secretion of total [35S]-labeled proteoglycans and mRNA of biglycan were increased to 116+/-1.8% and 121+/-11% (n=5, mean+/-S.E.M.) of unstimulated controls, respectively. Biglycan induction in response to AngII was sensitive to Losartan (10(-5) M) and unaffected by PD123177 (10(-6) M), suggesting that the AT(1)-receptor mediates the induction of biglycan. Direct activation of the biglycan promoter downstream of the AT(1)-receptor was excluded by promoter activity assays. Instead, increased release of transforming growth factor beta 1 (TGFbeta1) was detected by ELISA in response to AT(1)-receptor stimulation. Furthermore, neutralising antibodies to TGFbeta1 inhibited biglycan induction in response to AngII.
The results indicate that in cardiac fibroblasts AngII via the AT(1)-receptor causes autocrine release of TGFbeta1, which in turn induces biglycan expression and secretion.</description><identifier>ISSN: 0008-6363</identifier><identifier>PMID: 14659799</identifier><language>eng</language><publisher>England</publisher><subject>Angiotensin II - pharmacology ; Animals ; Animals, Newborn ; Anti-Arrhythmia Agents - pharmacology ; Autocrine Communication ; Biglycan ; Extracellular Matrix Proteins ; Fibroblasts - metabolism ; Gene Expression - drug effects ; Losartan - pharmacology ; Myocardial Infarction - metabolism ; Myocardium - metabolism ; Proteoglycans - analysis ; Proteoglycans - genetics ; Proteoglycans - metabolism ; Rats ; Rats, Inbred WKY ; Receptor, Angiotensin, Type 2 - metabolism ; Reverse Transcriptase Polymerase Chain Reaction ; RNA, Messenger - analysis ; Transforming Growth Factor beta - metabolism</subject><ispartof>Cardiovascular research, 2003-12, Vol.60 (3), p.538-546</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14659799$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tiede, Karen</creatorcontrib><creatorcontrib>Stöter, Katrin</creatorcontrib><creatorcontrib>Petrik, Christian</creatorcontrib><creatorcontrib>Chen, Wen Bin</creatorcontrib><creatorcontrib>Ungefroren, Hendrik</creatorcontrib><creatorcontrib>Kruse, Marie Luise</creatorcontrib><creatorcontrib>Stoll, Monika</creatorcontrib><creatorcontrib>Unger, Thomas</creatorcontrib><creatorcontrib>Fischer, Jens W</creatorcontrib><title>Angiotensin II AT(1)-receptor induces biglycan in neonatal cardiac fibroblasts via autocrine release of TGFbeta in vitro</title><title>Cardiovascular research</title><addtitle>Cardiovasc Res</addtitle><description>After myocardial infarction, angiotensin II (AngII) promotes ventricular remodeling and deposition of extracellular matrix (ECM), e.g., collagen type 1 and 3. Whether AngII regulates the expression of small leucine-rich proteoglycans (SLRP) which are important modulators of collagen fibrillogenesis and are induced after experimental myocardial infarction in rats is not known. The aim of the present study was therefore to analyse in cultured cardiac fibroblasts the expression and secretion of the SLRP biglycan in response to AngII.
Cardiac fibroblasts were isolated from neonatal Wistar Kyoto rats and used in the first passage. Expression of AT(1)- and AT(2)-receptors was verified by RT-PCR. Expression of protoeglycans was analyzed after metabolic labeling with [35S]-sulfate, by SDS-PAGE and Western analysis. In addition, mRNA expression was examined by means of RT-PCR and Northern analysis. The activity of the biglycan promoter was analyzed using three biglycan promoter-luciferase fusion constructs.
Biglycan was found to be the predominant proteoglycan produced by neonatal cardiac fibroblasts in vitro. In response to AngII (10(-7) M), secretion of total [35S]-labeled proteoglycans and mRNA of biglycan were increased to 116+/-1.8% and 121+/-11% (n=5, mean+/-S.E.M.) of unstimulated controls, respectively. Biglycan induction in response to AngII was sensitive to Losartan (10(-5) M) and unaffected by PD123177 (10(-6) M), suggesting that the AT(1)-receptor mediates the induction of biglycan. Direct activation of the biglycan promoter downstream of the AT(1)-receptor was excluded by promoter activity assays. Instead, increased release of transforming growth factor beta 1 (TGFbeta1) was detected by ELISA in response to AT(1)-receptor stimulation. Furthermore, neutralising antibodies to TGFbeta1 inhibited biglycan induction in response to AngII.
The results indicate that in cardiac fibroblasts AngII via the AT(1)-receptor causes autocrine release of TGFbeta1, which in turn induces biglycan expression and secretion.</description><subject>Angiotensin II - pharmacology</subject><subject>Animals</subject><subject>Animals, Newborn</subject><subject>Anti-Arrhythmia Agents - pharmacology</subject><subject>Autocrine Communication</subject><subject>Biglycan</subject><subject>Extracellular Matrix Proteins</subject><subject>Fibroblasts - metabolism</subject><subject>Gene Expression - drug effects</subject><subject>Losartan - pharmacology</subject><subject>Myocardial Infarction - metabolism</subject><subject>Myocardium - metabolism</subject><subject>Proteoglycans - analysis</subject><subject>Proteoglycans - genetics</subject><subject>Proteoglycans - metabolism</subject><subject>Rats</subject><subject>Rats, Inbred WKY</subject><subject>Receptor, Angiotensin, Type 2 - metabolism</subject><subject>Reverse Transcriptase Polymerase Chain Reaction</subject><subject>RNA, Messenger - analysis</subject><subject>Transforming Growth Factor beta - metabolism</subject><issn>0008-6363</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1UFFLwzAY7IPi5vQvSJ5EHwqJTdPkcQw3BwNf-l6-pF9GpEtqkg73762oL3fccRzcXRVLSqksRSWqRXGb0scs67rhN8WCcVGrRqll8bX2Rxcy-uQ82e_Jun1iz2VEg2MOkTjfTwYT0e44XAz42SAeg4cMAzEQeweGWKdj0AOknMjZAYEpBxOdRxJxQEhIgiXtbqsxw0_B2eUY7oprC0PC-z9eFe32td28lYf33X6zPpRjzVXJRd8whL63VNYMOKAVL1xYLZW0KKjqGyFMLYFq2lhlpWFGCtBMqhlBVKvi8bd2jOFzwpS7k0sGhwHmGVPqGsYrriSbgw9_wUmfsO_G6E4QL93_VdU36ullrg</recordid><startdate>20031201</startdate><enddate>20031201</enddate><creator>Tiede, Karen</creator><creator>Stöter, Katrin</creator><creator>Petrik, Christian</creator><creator>Chen, Wen Bin</creator><creator>Ungefroren, Hendrik</creator><creator>Kruse, Marie Luise</creator><creator>Stoll, Monika</creator><creator>Unger, Thomas</creator><creator>Fischer, Jens W</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20031201</creationdate><title>Angiotensin II AT(1)-receptor induces biglycan in neonatal cardiac fibroblasts via autocrine release of TGFbeta in vitro</title><author>Tiede, Karen ; Stöter, Katrin ; Petrik, Christian ; Chen, Wen Bin ; Ungefroren, Hendrik ; Kruse, Marie Luise ; Stoll, Monika ; Unger, Thomas ; Fischer, Jens W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p549-46d71eaddf0851a4aef6246fb898fe609d766c58a0b07f9f8c1c86ab1896aba63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Angiotensin II - pharmacology</topic><topic>Animals</topic><topic>Animals, Newborn</topic><topic>Anti-Arrhythmia Agents - pharmacology</topic><topic>Autocrine Communication</topic><topic>Biglycan</topic><topic>Extracellular Matrix Proteins</topic><topic>Fibroblasts - metabolism</topic><topic>Gene Expression - drug effects</topic><topic>Losartan - pharmacology</topic><topic>Myocardial Infarction - metabolism</topic><topic>Myocardium - metabolism</topic><topic>Proteoglycans - analysis</topic><topic>Proteoglycans - genetics</topic><topic>Proteoglycans - metabolism</topic><topic>Rats</topic><topic>Rats, Inbred WKY</topic><topic>Receptor, Angiotensin, Type 2 - metabolism</topic><topic>Reverse Transcriptase Polymerase Chain Reaction</topic><topic>RNA, Messenger - analysis</topic><topic>Transforming Growth Factor beta - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tiede, Karen</creatorcontrib><creatorcontrib>Stöter, Katrin</creatorcontrib><creatorcontrib>Petrik, Christian</creatorcontrib><creatorcontrib>Chen, Wen Bin</creatorcontrib><creatorcontrib>Ungefroren, Hendrik</creatorcontrib><creatorcontrib>Kruse, Marie Luise</creatorcontrib><creatorcontrib>Stoll, Monika</creatorcontrib><creatorcontrib>Unger, Thomas</creatorcontrib><creatorcontrib>Fischer, Jens W</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Cardiovascular research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tiede, Karen</au><au>Stöter, Katrin</au><au>Petrik, Christian</au><au>Chen, Wen Bin</au><au>Ungefroren, Hendrik</au><au>Kruse, Marie Luise</au><au>Stoll, Monika</au><au>Unger, Thomas</au><au>Fischer, Jens W</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Angiotensin II AT(1)-receptor induces biglycan in neonatal cardiac fibroblasts via autocrine release of TGFbeta in vitro</atitle><jtitle>Cardiovascular research</jtitle><addtitle>Cardiovasc Res</addtitle><date>2003-12-01</date><risdate>2003</risdate><volume>60</volume><issue>3</issue><spage>538</spage><epage>546</epage><pages>538-546</pages><issn>0008-6363</issn><abstract>After myocardial infarction, angiotensin II (AngII) promotes ventricular remodeling and deposition of extracellular matrix (ECM), e.g., collagen type 1 and 3. Whether AngII regulates the expression of small leucine-rich proteoglycans (SLRP) which are important modulators of collagen fibrillogenesis and are induced after experimental myocardial infarction in rats is not known. The aim of the present study was therefore to analyse in cultured cardiac fibroblasts the expression and secretion of the SLRP biglycan in response to AngII.
Cardiac fibroblasts were isolated from neonatal Wistar Kyoto rats and used in the first passage. Expression of AT(1)- and AT(2)-receptors was verified by RT-PCR. Expression of protoeglycans was analyzed after metabolic labeling with [35S]-sulfate, by SDS-PAGE and Western analysis. In addition, mRNA expression was examined by means of RT-PCR and Northern analysis. The activity of the biglycan promoter was analyzed using three biglycan promoter-luciferase fusion constructs.
Biglycan was found to be the predominant proteoglycan produced by neonatal cardiac fibroblasts in vitro. In response to AngII (10(-7) M), secretion of total [35S]-labeled proteoglycans and mRNA of biglycan were increased to 116+/-1.8% and 121+/-11% (n=5, mean+/-S.E.M.) of unstimulated controls, respectively. Biglycan induction in response to AngII was sensitive to Losartan (10(-5) M) and unaffected by PD123177 (10(-6) M), suggesting that the AT(1)-receptor mediates the induction of biglycan. Direct activation of the biglycan promoter downstream of the AT(1)-receptor was excluded by promoter activity assays. Instead, increased release of transforming growth factor beta 1 (TGFbeta1) was detected by ELISA in response to AT(1)-receptor stimulation. Furthermore, neutralising antibodies to TGFbeta1 inhibited biglycan induction in response to AngII.
The results indicate that in cardiac fibroblasts AngII via the AT(1)-receptor causes autocrine release of TGFbeta1, which in turn induces biglycan expression and secretion.</abstract><cop>England</cop><pmid>14659799</pmid><tpages>9</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0008-6363 |
| ispartof | Cardiovascular research, 2003-12, Vol.60 (3), p.538-546 |
| issn | 0008-6363 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_71434981 |
| source | MEDLINE; Oxford University Press Journals All Titles (1996-Current); EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| subjects | Angiotensin II - pharmacology Animals Animals, Newborn Anti-Arrhythmia Agents - pharmacology Autocrine Communication Biglycan Extracellular Matrix Proteins Fibroblasts - metabolism Gene Expression - drug effects Losartan - pharmacology Myocardial Infarction - metabolism Myocardium - metabolism Proteoglycans - analysis Proteoglycans - genetics Proteoglycans - metabolism Rats Rats, Inbred WKY Receptor, Angiotensin, Type 2 - metabolism Reverse Transcriptase Polymerase Chain Reaction RNA, Messenger - analysis Transforming Growth Factor beta - metabolism |
| title | Angiotensin II AT(1)-receptor induces biglycan in neonatal cardiac fibroblasts via autocrine release of TGFbeta in vitro |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T18%3A54%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Angiotensin%20II%20AT(1)-receptor%20induces%20biglycan%20in%20neonatal%20cardiac%20fibroblasts%20via%20autocrine%20release%20of%20TGFbeta%20in%20vitro&rft.jtitle=Cardiovascular%20research&rft.au=Tiede,%20Karen&rft.date=2003-12-01&rft.volume=60&rft.issue=3&rft.spage=538&rft.epage=546&rft.pages=538-546&rft.issn=0008-6363&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E71434981%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71434981&rft_id=info:pmid/14659799&rfr_iscdi=true |